Phase II Study of Carfilzomib in Patients With Refractory Renal Cell Carcinoma
Phase of Trial: Phase II
Latest Information Update: 05 Feb 2019
At a glance
- Drugs Carfilzomib (Primary)
- Indications Renal cancer; Renal cell carcinoma
- Focus Therapeutic Use
- 25 Jan 2019 Status changed from active, no longer recruiting to completed.
- 20 May 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 26 Oct 2013 New source identified and integrated (M.D. Anderson Cancer Center, 2012-0694).